Latest Developments in Global Ai Driven Clinical Decision Support Systems Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Ai Driven Clinical Decision Support Systems Market

  • Healthcare
  • May 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In May 2024, WELL Health Technologies Corp. launched HEALWELL AI, a second-generation WELL AI Decision Support (WAIDS). The upgraded WAIDS includes screening capabilities for numerous chronic diseases such as chronic kidney disease, hypertension, and diabetes, enabling risk stratification of patients into high-, medium-, or low-risk categories. This expansion broadens WAIDS's utility in detecting more than 100 rare and chronic diseases, providing clinically validated insights that identify care gaps and equip clinicians with actionable information at the point of care
  • In February 2024, Elsevier Health, in partnership with OpenEvidence, launched ClinicalKey AI, the first and most advanced clinical decision support tool in the United States that combines the latest and most trusted medical content with generative artificial intelligence (AI) to help clinicians at the point of care
  • In April 2023, Microsoft (US) and Epic Systems Corporation (US) expanded their long-standing strategic collaboration to develop and integrate generative AI into healthcare by combining the scale and power of Azure OpenAI Service with Epic’s industry-leading electronic health record (EHR) software. This co-innovation is focused on delivering a comprehensive array of generative AI- powered solutions integrated with Epic’s EHR to increase productivity, enhance patient care, and improve financial integrity of health systems globall
  • In April 2023, Elsevier B.V. (UK) announced the launch of an upgraded version of its clinical decision support solution, ClinicalKey. This enhanced platform incorporates a comprehensive drug compendium, a cutting-edge mobile application, and seamless integration into Electronic Health Records (EHR). These new features have been strategically designed to offer physicians in the United States and international markets convenient access to reliable and extensive medical content directly at the point of care, speeding up diagnosis and treatment for their patients
  • In February 2023, The province of Nova Scotia, in collaboration with Nova Scotia Health Authority (NSHA) and IWK Health (IWK) entered into a new 10-year agreement has been signed with Oracle (US) to implement an integrated electronic care record across the province for the more than one million Nova Scotians. This technology can help improve the way health professionals use and share patient information